,,

Qiaoling Zhang1, Ling Lin1, Gui Chen1

  • 1Department of Laboratory Medicine, Dongguan Key Laboratory of Innovative Molecular Imaging, Dongguan Institute of Clinical Cancer Research, The Tenth Affiliated Hospital (Dongguan People's Hospital), Southern Medical University, Dongguan, 523058, China; Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, 510515, China.

Biomaterials
|July 13, 2025
PubMed
概括

这项研究介绍了CLRN,一种新型的纳米诱导剂,它破坏瘤稳态,触发免疫细胞死亡并增强对癌症的免疫反应. 通过促进热致死和逆转免疫抑制性瘤微环境,CLRN有效抑制瘤生长.